Jushi Holdings Inc.
General ticker "JUSHF" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $84.8M (TTM average)
Jushi Holdings Inc. follows the US Stock Market performance with the rate: 45.5%.
Estimated limits based on current volatility of 5.3%: low 0.47$, high 0.53$
Factors to consider:
- Total employees count: 1234 (+3.9%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Immaturity of cannabis industry, Strategic risks and growth management, Labor/talent shortage/retention, Market competition, Litigation risks
- Current price 14.3% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.13$, 0.44$]
- 2025-12-31 to 2026-12-31 estimated range: [0.10$, 0.34$]
Financial Metrics affecting the JUSHF estimates:
- Positive: with PPE of -1.2 at the end of fiscal year the price was low
- Positive: -3.60 < Operating profit margin, % of 4.22
- Positive: Operating cash flow per share per price, % of 39.11 > 13.24
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of -1.41 <= -0.15
- Positive: -14.38 < Investing cash flow per share per price, % of -12.82
- Negative: negative Industry operating cash flow (median)
Short-term JUSHF quotes
Long-term JUSHF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $284.28MM | $269.44MM | $257.52MM |
| Operating Expenses | $504.62MM | $272.26MM | $246.66MM |
| Operating Income | $-220.33MM | $-2.82MM | $10.86MM |
| Non-Operating Income | $26.46MM | $-30.48MM | $-28.01MM |
| Interest Expense | $45.59MM | $36.97MM | $37.42MM |
| Income(Loss) | $-193.88MM | $-33.30MM | $-17.15MM |
| Taxes | $8.45MM | $31.81MM | $31.63MM |
| Profit(Loss)* | $-202.32MM | $-65.10MM | $-48.78MM |
| Stockholders Equity | $47.28MM | $-6.23MM | $-50.23MM |
| Inventory | $35.09MM | $33.41MM | $36.14MM |
| Assets | $529.34MM | $463.39MM | $440.32MM |
| Operating Cash Flow | $-21.42MM | $-3.32MM | $21.57MM |
| Capital expenditure | $56.88MM | $10.94MM | $4.71MM |
| Investing Cash Flow | $-80.86MM | $-6.39MM | $-7.07MM |
| Financing Cash Flow | $33.98MM | $13.87MM | $-24.46MM |
| Earnings Per Share** | $-1.06 | $-0.33 | $-0.25 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.